Avoiding Diabetes After Pregnancy Trial

NACompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Weight Reduction
Interventions
BEHAVIORAL

Weight Reduction Intervention

"The weight trial intervention components were:~* Electronic feedback from the ADAPT interactive obesity treatment approach (iOTA) system, tracking participants' behavior change goals. Participants received feedback either by daily SMS (text messaging) or by weekly IVR (interactive automated calls).~* Seven behavior change coaching calls, once a month for 6 months, and then one at 7.5 months halfway through the maintenance period.~* Print mailings/emailings~* 3 Get Ready e-messages in the four weeks before the weight intervention began~* Pedometers and program guides. (IVR users received printed activity logs with their program guides.)~* Access to the ADAPT iOTA website for reviewing their progress and obtaining information on behavior change goals."

BEHAVIORAL

Weight Reduction Control Arm

Participants received an initial brochure about managing diabetes risk, a digital scale to use in entering their weights in online questionnaires, and monthly emailed wellness messages unrelated to diabetes.

BEHAVIORAL

Tested for diabetes

Due to small numbers in this group, the planned intervention was changed to a mixed-mode study, using baseline and follow-up self-administered questionnaires and semi-structured questionnaires administered to a sub-sample of those tested for diabetes to identify factors differentiating the behavior of women who had and had not been tested for diabetes following a pregnancy with gestational diabetes mellitus.

BEHAVIORAL

Not tested for diabetes

Due to small numbers in this group, the planned intervention was changed to a mixed-mode study, using baseline and follow-up self-administered questionnaires and semi-structured questionnaires administered to a subsample of those not tested for diabetes to identify factors differentiating the behavior of women who had and had not been tested for diabetes following a pregnancy with gestational diabetes mellitus.

Trial Locations (1)

20910

Social & Scientific Systems Inc., Silver Spring

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Harvard Pilgrim Health Care

OTHER

collaborator

Duke University

OTHER

collaborator

Harvard Vanguard Medical Associates

OTHER

lead

Social & Scientific Systems Inc.

INDUSTRY

NCT01923350 - Avoiding Diabetes After Pregnancy Trial | Biotech Hunter | Biotech Hunter